FBT
First Trust NYSE Arca Biotechnology Index Fund
Price Chart
Latest Quote
$279.50
+5.77 (+2.11%)
Current Price
| Previous Close | $273.73 |
| Open | $271.85 |
| Day High | $279.96 |
| Day Low | $271.26 |
| Volume | 92,538 |
Fund Information
| Shares Outstanding | 20.85M |
| Net Assets | $2.97B |
| Expense Ratio | 0.55% |
| Category | Health |
| Fund Family | First Trust |
| Net Asset Value | $273.57 |
| Premium/Discount | 2.17% |
| P/E Ratio | 30.42 |
| Exchange | PCX |
đ ETF Analysis
Company Data
| Book/sh | $172.68 |
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 1.62 |
Analyst Data
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 66.32 |
| ATR | nan |
| Rel Volume | 1.41 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| 6 Months | nan% |
| YTD | nan% |
| Year | nan% |
| 3 Years | nan% |
| 5 Years | nan% |
| 10 Years | nan% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-28 | $nan | 92,538 |
| 2026-10-27 | $273.73 | 47,600 |
| 2026-10-26 | $271.47 | 64,500 |
| 2026-10-23 | $269.25 | 60,200 |
| 2026-10-22 | $272.68 | 55,300 |
| 2026-10-21 | $272.46 | 58,500 |
| 2026-10-20 | $271.77 | 82,600 |
| 2026-10-19 | $265.48 | 38,600 |
| 2026-10-16 | $263.60 | 49,300 |
| 2026-10-15 | $268.39 | 55,500 |
| 2026-10-14 | $262.95 | 39,800 |
| 2026-10-13 | $259.65 | 44,900 |
| 2026-10-12 | $263.90 | 26,300 |
| 2026-10-09 | $265.40 | 187,300 |
| 2026-10-08 | $260.19 | 72,500 |
| 2026-10-07 | $263.49 | 63,900 |
| 2026-10-06 | $264.97 | 71,500 |
| 2026-10-05 | $270.93 | 51,000 |
| 2026-10-02 | $266.44 | 51,100 |
| 2026-10-01 | $265.79 | 96,600 |
| 2026-09-30 | $272.26 | 101,400 |
| 2026-09-29 | $272.58 | 37,600 |
About First Trust NYSE Arca Biotechnology Index Fund
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
đ° Latest News
No news articles available at the moment. Check back later for updates on FBT.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.